CompletedNot Applicable

BCC Excision Revisited

Austria451 participantsStarted 2019-11-12

Plain-language summary

To readdress basal cell carcinoma (BCC) in the periocular region to prove histologically controlled surgical treatment efficacy and to identify high-risk characteristics.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Patient records were reviewed for the presence of BCC and surgical excision with frozen sections control of the wound margins in the periocular region, * conducted between 01.01.2009 and 31.12.2019. * Periocular was defined as the area involving the medial and lateral canthus as well as the upper and lower eyelids. Exclusion criteria: * BCCs outside of this region were excluded from this analysis, * as well as incomplete records.

What they're measuring

BCC Recurrence

Timeframe: mean 3-5 years

Trial details

NCT IDNCT05853315

SponsorMedical University of Vienna

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-04-01

View on ClinicalTrials.gov More Basal Cell Carcinoma trials